European equities traded in the US as American depositary receipts were tracking higher late Thursday morning, rising 0.63% to 1,651.45 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and accommodations booking site trivago (TRVG), which rose 5.6% and 4.8%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which increased 3.9% and 2%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and furniture manufacturer Natuzzi (NTZ), which dropped 6.6% and 5%, respectively. They were followed by biopharmaceutical company argenx (ARGX) and pharmaceutical company Ascendis Pharma (ASND), which lost 1.4% and 1.1%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which advanced 4.1% and 2.9%, respectively. They were followed by biopharmaceutical company Amarin (AMRN) and lender Barclays (BCS), which were up 1.8% and 1.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which fell 21% and 7.5%, respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were down 2% each.